Hydroxychloroquine combination risky for cancer patients with COVID-19: Study

The preliminary results suggest doctors may want to refrain from prescribing the decades-old malaria treatment hydroxychloroquine with the antibiotic azithromycin for these patients until more study is done, researchers said.

from Moneycontrol Latest News https://ift.tt/2XCqXxy